1. Home
  2. DNA vs MAGN Comparison

DNA vs MAGN Comparison

Compare DNA & MAGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$6.94

Market Cap

458.6M

Sector

Health Care

ML Signal

HOLD

Logo Magnera Corporation

MAGN

Magnera Corporation

HOLD

Current Price

$11.99

Market Cap

435.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNA
MAGN
Founded
2008
1864
Country
United States
United States
Employees
N/A
2980
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Paper
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
458.6M
435.4M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
DNA
MAGN
Price
$6.94
$11.99
Analyst Decision
Hold
Hold
Analyst Count
2
1
Target Price
$8.50
$12.00
AVG Volume (30 Days)
1.2M
366.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
46.49
7.64
EPS
N/A
N/A
Revenue
$170,155,000.00
$3,204,000,000.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
$3.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
46.50
52 Week Low
$5.37
$7.82
52 Week High
$17.58
$15.52

Technical Indicators

Market Signals
Indicator
DNA
MAGN
Relative Strength Index (RSI) 44.55 43.24
Support Level $6.30 $11.64
Resistance Level $7.10 $12.96
Average True Range (ATR) 0.47 0.50
MACD 0.03 0.00
Stochastic Oscillator 27.47 21.93

Price Performance

Historical Comparison
DNA
MAGN

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About MAGN Magnera Corporation

Magnera Corp is a supplier of a diverse portfolio of specialty materials comprised of organic and synthetic raw ingredients. The company markets its own products predominantly into stable, consumer-oriented end markets, including wipes, healthcare, adult incontinence, apparel, baby, feminine care, air filtration, and food and beverage, for disposable and durable applications. It also provides technical solutions in infrastructure markets. The company's operations are organized into two operating and reportable segments: Americas and Rest of World. It derives the majority of its revenue from the Americas, which manufactures products and components of personal care, including medical garments, wipes, dryer sheets, filtration, baby diapers and adult incontinence.

Share on Social Networks: